This website collects cookies to deliver better user experience. Cookie Policy
Accept
Sign In
The Wall Street Publication
  • Home
  • Trending
  • U.S
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Markets
    • Personal Finance
  • Tech
  • Lifestyle
    • Lifestyle
    • Style
    • Arts
  • Health
  • Sports
  • Entertainment
Reading: Companies Bet You’re Ready to Test at Home for More Than Covid-19
Share
The Wall Street PublicationThe Wall Street Publication
Font ResizerAa
Search
  • Home
  • Trending
  • U.S
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Markets
    • Personal Finance
  • Tech
  • Lifestyle
    • Lifestyle
    • Style
    • Arts
  • Health
  • Sports
  • Entertainment
Have an existing account? Sign In
Follow US
© 2024 The Wall Street Publication. All Rights Reserved.
The Wall Street Publication > Blog > Tech > Companies Bet You’re Ready to Test at Home for More Than Covid-19
Tech

Companies Bet You’re Ready to Test at Home for More Than Covid-19

Editorial Board Published March 3, 2022
Share
Companies Bet You’re Ready to Test at Home for More Than Covid-19
SHARE

The Covid-19 pandemic has hastened consumers’ willingness to test for more medical conditions at home, test makers said, expanding the market for self-diagnostic products.

Contents
Newsletter Sign-upThe 10-Point.SHARE YOUR THOUGHTSAn at-home Covid-19 test from Cue Health uses an electronic reader.The Omicron Variant

Manufacturers are developing new types of at-home tests, including for flu and strep throat, aimed at consumers who are increasingly monitoring and managing their own health through fitness apps and smartwatches.

Boulder, Colo.-based fertility company MFB Fertility Inc. received clearance from the U.S. Food and Drug Administration in February 2020 for its Proov test, designed to help women measure their hormone levels and to know when in a given month they are most likely to become pregnant. A typical kit includes 20 testing strips, allowing a woman to test daily, which the company said would be tough to achieve through visits to a doctor’s office.

Amy Beckley, the company’s chief executive, said the rise of at-home Covid-19 tests over the past year has made it much easier for people to understand her product.

“All of a sudden, home diagnostics and home testing became a thing,” she said.


Newsletter Sign-up

The 10-Point.

A personal, guided tour to the best scoops and stories every day in The Wall Street Journal.


Growth in rapid, at-home testing follows decades of development and lobbying from test makers and public-health and medical groups, said Nitika Pant Pai, a medical professor at McGill University who studies rapid tests.

Home tests can help more people know whether they are sick and can be faster, less costly and more convenient than laboratory-based tests, Dr. Pai said. Before Covid-19 began spreading world-wide, she said, some medical professionals and public-health officials had been reluctant to embrace at-home testing over concerns that the general public wouldn’t know how to perform a test, or overreact to results without doctors’ guidance.

Some home-based tests, including for pregnancy and blood-sugar monitoring, have been around for decades. In 2012 the FDA approved the first at-home test for HIV, the virus that causes AIDS.

Manufacturers, testing experts and government regulators said there is enough interest in, and familiarity with, at-home testing that new tests are likely to reach consumers in the coming years.

“Covid has paved the way for home testing,” Dr. Pai said.

New high-tech Covid-19 tests promise better and earlier detection of the virus—similar to a PCR test. WSJ’s Joanna Stern (and her mannequin clone) tried out the Detect Covid-19 Test and Cue Health Monitoring System to see how they compare with rapid antigen tests. Photo illustration: Ryan Trefes/ WSJ

Some tests, such as those for testing stool for blood, rely on consumers to perform an action themselves and then send the test by mail to a laboratory. Others offer in-home results in minutes using lines that appear on test strips, phone applications or physical readers.

The most complicated tests still need to be done in laboratory settings, with samples typically collected by medical professionals. The FDA allows simpler tests, including for influenza and hemoglobin, to be performed directly in doctors’ offices, typically using automated machines. States have started to allow pharmacists to perform some types of testing directly in stores.

SHARE YOUR THOUGHTS

What is your outlook for at-home healthcare? Join the conversation below.

Some rapid-testing options recommend that patients confirm results with laboratory-based testing. Los Angeles-based Medical Electronic Systems LLC makes laboratory-grade equipment and at-home products for testing male fertility. The company said FDA reviewers wanted the company to simplify how its home testing kit reported results to users so that they weren’t confused, according to general manager Eric Carver. The test’s phone application tells users to see a fertility specialist if their results are abnormal.

Some of the biggest competitors in laboratory testing are also expanding at-home testing options in response to rising consumer demand. Laboratory Corp. of America Holdings, better known as Labcorp, and Quest Diagnostics Inc. have rolled out platforms that let consumers order tests for fertility, blood iron levels and cancer. Some of their offerings have patients draw blood or collect other samples themselves and ship them to a laboratory, while others have customers schedule visits to local collection centers. Rapid tests are typically less accurate than laboratory-based ones, testing experts said, much like laboratory-based PCR tests for Covid-19 are more accurate than at-home rapid antigen tests.

Quest’s consumer-testing service already had $70 million in revenue in 2021 and expects that to grow to $250 million by 2025, the company says.

Cathy Doherty, an executive at Quest in charge of the consumer-testing business, said Quest’s research shows that consumers are interested in a wider range of at-home tests, but many still prefer visiting a doctor’s office or testing center to make sure the tests are performed correctly.

“We think that there is room for both,” she said.

An at-home Covid-19 test from Cue Health uses an electronic reader.

Photo: Cue Health

In February, Labcorp relaunched an online service allowing consumers to order some tests directly from the company. The company is evaluating whether rapid tests that deliver results at home are high-quality enough to be included in the service, said Chief Marketing Officer Amy Summy. She said that people should continue going to medical professionals for serious issues.

The pandemic has sped up development of some at-home testing capabilities. Detect Inc. was founded at the start of the pandemic to develop an at-home Covid-19 test that was closer in accuracy to laboratory-based tests. The test won emergency approval in October 2021. Now the company is working on using its platform for future tests, including a strep-throat test and a joint Covid-19-flu test, said Owen Kaye-Kauderer, Detect’s chief business officer.

San Diego-based Cue Health Inc. has been working on an at-home testing system for the flu and other diseases since 2010. Its first product to get FDA emergency approval was an at-home Covid-19 test that uses an electronic reader plus molecular cartridges for each laboratory-like test.

Cue is in active clinical trials for its at-home flu test and is developing others, including for chlamydia. The company, which ran a Super Bowl advertisement earlier this year, has invested $250 million in expanding its U.S. factories that produce its tests and building a U.S.-centric supply chain, with the help of government and private funding. The company reported preliminary 2021 revenue of roughly $616 million, up from $23 million in 2020, with almost all of it linked to Covid-19 testing.

“One of the most important, enduring changes in the pandemic will be a shift in how people view diagnostics at home,” Chief Executive Ayub Khattak said. “It is better for people to have access to information more quickly.”

The Omicron Variant

Write to Austen Hufford at [email protected]

Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

TAGGED:Tech NewsWall Street Publication
Share This Article
Twitter Email Copy Link Print
Previous Article Elon Musk Invites UAW to Hold Union Vote at Tesla Elon Musk Invites UAW to Hold Union Vote at Tesla
Next Article Are At-Home Food Sensitivity Tests a Waste of Money? Are At-Home Food Sensitivity Tests a Waste of Money?

Editor's Pick

Kirill Dmitriev’s Vision: The Russia-Alaska Tunnel as a Geostrategic Imperative

Kirill Dmitriev’s Vision: The Russia-Alaska Tunnel as a Geostrategic Imperative

Executive Summary: A Strategic Announcement In a landmark social media post dated October 16, Kirill Dmitriev, Chief Executive Officer of…

By Editorial Board 6 Min Read
10 Upcoming Sneaker Drops You Can’t Miss This October | Fashion
10 Upcoming Sneaker Drops You Can’t Miss This October | Fashion

We independently consider all beneficial services and products. Any services or products…

7 Min Read
The 2025 Denim Playbook: The Finest Denims and Manufacturers for Each Type | Fashion
The 2025 Denim Playbook: The Finest Denims and Manufacturers for Each Type | Fashion

We independently consider all advisable services. Any services or products put ahead…

6 Min Read

Oponion

Earlier than You Purchase One other Complement, Learn This First

Earlier than You Purchase One other Complement, Learn This First

In case your Instagram feed is something like mine, must-try…

October 24, 2024

Investors Pile Into Gold, Seeking Safety From Market, Geopolitical Turbulence

One asset holding up through the…

January 25, 2022

Toyota Softens Toward Critics of Its EV Push

Listen to article(2 minutes)Toyota Motor wants…

September 25, 2022

Tax invoice exhibits Home GOP is not critical about federal deficit

The Committee for a Accountable Federal…

May 16, 2025

Move over, Izzy; Paris mascot now reigns as Olympics’ worst

ATLANTA — Hey, Izzy, we’ve got…

November 15, 2022

You Might Also Like

I Take a look at-Drove Maeving’s New RM2 Electrical Bike
Tech

I Take a look at-Drove Maeving’s New RM2 Electrical Bike

I test-ride electrical kick scooters as part of my job. They're unbelievable to trip and zip round city, however they…

3 Min Read
Google’s Tremendous Good New Nest Cameras Increase the Bar—and the Value
Tech

Google’s Tremendous Good New Nest Cameras Increase the Bar—and the Value

The brand new Nest Cam Indoor and Nest Cam Out of doors boast the simplest setup expertise I’ve encountered. Merely…

5 Min Read
If You Like Thuma’s Frames, You Would possibly Need to Look Into Thuma’s Mattress
Tech

If You Like Thuma’s Frames, You Would possibly Need to Look Into Thuma’s Mattress

The Thuma Hybrid affords three firmness choices: Plush, Medium, and Agency. I selected Medium as a result of my companion…

4 Min Read
I Love Testing Exercise Headphones As a result of I am All the time Puttering Round
Tech

I Love Testing Exercise Headphones As a result of I am All the time Puttering Round

Evaluate Prime 5 Exercise HeadphonesThe best way to Preserve Your In-Ear Headphones From Falling OutAccordionItemContainerButtonTo a sure extent, how the…

10 Min Read
The Wall Street Publication

About Us

The Wall Street Publication, a distinguished part of the Enspirers News Group, stands as a beacon of excellence in journalism. Committed to delivering unfiltered global news, we pride ourselves on our trusted coverage of Politics, Business, Technology, and more.

Company

  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • WP Creative Group
  • Accessibility Statement

Contact

  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability

Term of Use

  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices

© 2024 The Wall Street Publication. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?